Overall Survival With Adjuvant mFOLFIRINOX for Pancreatic Cancer

被引：0
|
作者：
Reni, Michele [1 ,3 ]
Macchini, Marina [1 ]
Porcu, Luca [2 ]
机构：
[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst IRCCS, Pancreas Translat & Clin Res Ctr, Dept Med Oncol, Milan, Italy
[2] Ist Ric Farmacolog Mario Negri IRCCS, Oncol Dept, Methodol Clin Res Lab, Milan, Italy
[3] Univ Vita Salute San Raffaele, Pancreas Translat & ClinicalResearch Ctr, Dept Med Oncol, San Raffaele ScientificInstitute IRCCS, Via Olgettina 60, I-20132 Milan, Italy
来源：
JAMA ONCOLOGY | 2023年 / 9卷 / 03期
关键词：
D O I：
10.1001/jamaoncol.2022.7358
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：435 / 436
页数：2
相关论文
共 50 条
  • [31] Clinical Characteristics and Overall Survival in Patients with Anaplastic Pancreatic Cancer
    Clark, Clancy J.
    Arun, Janani S.
    Graham, Rondell P.
    Zhang, Lizhi
    Farnell, Michael
    Reid-Lombardo, Kaye M.
    AMERICAN SURGEON, 2014, 80 (02) : 117 - 123
  • [32] Pretreatment serum ferritin and overall survival in metastatic pancreatic cancer
    Zubritsky, Lindsey
    Alkhateeb, Ahmed
    Leitzel, Kim
    Ali, Suhail M.
    Campbell-Baird, Cynthia
    Connor, James
    Lipton, Allan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [33] Cytokines as a prognostic biomarker of overall survival in pancreatic cancer.
    Tan, Harold Nathan Choa
    Nona Velasco, Rogelio
    San Juan, Michael Ducusin
    Cornelio, Gerardo H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Expectations of overall survival for patients with metastatic pancreatic cancer (mPC).
    Willey, Joanne P.
    Buettner, Arden
    Britton, Susan Lynne
    Lankford, Maria L.
    Scharf, Mitchell
    Singh, Bhavana Pendurthi
    Lima, Caio Max Sao Pedro Rocha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] THE EFFECT OF NEOADJUVANT THERAPY ON OVERALL SURVIVAL IN RESECTED PANCREATIC CANCER
    Lancaster, William
    Adams, David
    Morgan, Katherine A.
    GASTROENTEROLOGY, 2019, 156 (06) : S1490 - S1491
  • [36] Gender differences in overall survival in patients with metastatic pancreatic cancer
    Taghizadeh, H.
    Wiesholzer, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S255 - S255
  • [37] Nomogram for Estimating Overall Survival in Patients With Metastatic Pancreatic Cancer
    Goldstein, David
    Von Hoff, Daniel D.
    Chiorean, E. Gabriela
    Reni, Michele
    Tabernero, Josep
    Ramanathan, Ramesh K.
    Botteman, Marc
    Aly, Abdalla
    Margunato-Debay, Sandra
    Lu, Brian
    Louis, Chrystal U.
    McGovern, Desmond
    Lee, Chee Khoon
    PANCREAS, 2020, 49 (06) : 744 - 750
  • [38] Adjuvant chemoradiation in resected gallbladder cancer: A prognostic model for overall survival
    Sole, C.
    Vargas, L.
    Sole, V.
    Larsen, F.
    Sole, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S407 - S407
  • [39] Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
    J. L. van Dam
    E. M. M. Verkolf
    E. N. Dekker
    B. A. Bonsing
    S. O. Bratlie
    L. A. A. Brosens
    O. R. Busch
    L. M. J. W. van Driel
    C. H. J. van Eijck
    S. Feshtali
    P. Ghorbani
    D. J. A. de Groot
    J. W. B. de Groot
    B. C. M. Haberkorn
    I. H. de Hingh
    B. van der Holt
    T. M. Karsten
    M. B. van der Kolk
    K. J. Labori
    M. S. L. Liem
    O. J. L. Loosveld
    I. Q. Molenaar
    M. B. Polée
    H. C. van Santvoort
    J. de Vos – Geelen
    M. L. Wumkes
    G. van Tienhoven
    M. Y. V. Homs
    M. G. Besselink
    J. W. Wilmink
    B. Groot Koerkamp
    BMC Cancer, 23
  • [40] Adjuvant osimertinib improves overall survival
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2023, 20 : 504 - 504
12345